nodes	percent_of_prediction	percent_of_DWPC	metapath
Fesoterodine—Pharyngolaryngeal pain—Varenicline—nicotine dependence	0.0398	0.0615	CcSEcCtD
Fesoterodine—Laryngeal pain—Varenicline—nicotine dependence	0.0394	0.0609	CcSEcCtD
Fesoterodine—Gastrooesophageal reflux disease—Varenicline—nicotine dependence	0.0297	0.046	CcSEcCtD
Fesoterodine—Dry eye—Varenicline—nicotine dependence	0.0248	0.0383	CcSEcCtD
Fesoterodine—Urinary retention—Varenicline—nicotine dependence	0.0185	0.0287	CcSEcCtD
Fesoterodine—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0182	0.0516	CbGpPWpGaD
Fesoterodine—Dry skin—Varenicline—nicotine dependence	0.0179	0.0276	CcSEcCtD
Fesoterodine—Abdominal pain upper—Varenicline—nicotine dependence	0.0178	0.0275	CcSEcCtD
Fesoterodine—Angina pectoris—Varenicline—nicotine dependence	0.0164	0.0254	CcSEcCtD
Fesoterodine—Abdominal discomfort—Varenicline—nicotine dependence	0.0161	0.025	CcSEcCtD
Fesoterodine—Infestation NOS—Varenicline—nicotine dependence	0.015	0.0232	CcSEcCtD
Fesoterodine—Infestation—Varenicline—nicotine dependence	0.015	0.0232	CcSEcCtD
Fesoterodine—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.0142	0.0403	CbGpPWpGaD
Fesoterodine—Hepatobiliary disease—Varenicline—nicotine dependence	0.0142	0.022	CcSEcCtD
Fesoterodine—Urinary tract disorder—Varenicline—nicotine dependence	0.0133	0.0206	CcSEcCtD
Fesoterodine—Oedema peripheral—Varenicline—nicotine dependence	0.0133	0.0205	CcSEcCtD
Fesoterodine—Urethral disorder—Varenicline—nicotine dependence	0.0132	0.0204	CcSEcCtD
Fesoterodine—Eye disorder—Varenicline—nicotine dependence	0.0126	0.0195	CcSEcCtD
Fesoterodine—Cardiac disorder—Varenicline—nicotine dependence	0.0125	0.0193	CcSEcCtD
Fesoterodine—Mediastinal disorder—Varenicline—nicotine dependence	0.0121	0.0188	CcSEcCtD
Fesoterodine—Mental disorder—Varenicline—nicotine dependence	0.0118	0.0183	CcSEcCtD
Fesoterodine—Flatulence—Varenicline—nicotine dependence	0.0116	0.0179	CcSEcCtD
Fesoterodine—Dysgeusia—Varenicline—nicotine dependence	0.0115	0.0178	CcSEcCtD
Fesoterodine—Back pain—Varenicline—nicotine dependence	0.0113	0.0176	CcSEcCtD
Fesoterodine—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.0113	0.032	CbGpPWpGaD
Fesoterodine—Vision blurred—Varenicline—nicotine dependence	0.0111	0.0171	CcSEcCtD
Fesoterodine—Angioedema—Varenicline—nicotine dependence	0.0107	0.0166	CcSEcCtD
Fesoterodine—Vertigo—Varenicline—nicotine dependence	0.0105	0.0163	CcSEcCtD
Fesoterodine—Palpitations—Varenicline—nicotine dependence	0.0104	0.016	CcSEcCtD
Fesoterodine—Cough—Varenicline—nicotine dependence	0.0102	0.0158	CcSEcCtD
Fesoterodine—Chest pain—Varenicline—nicotine dependence	0.00999	0.0154	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00992	0.0153	CcSEcCtD
Fesoterodine—Dry mouth—Varenicline—nicotine dependence	0.00977	0.0151	CcSEcCtD
Fesoterodine—Infection—Varenicline—nicotine dependence	0.00951	0.0147	CcSEcCtD
Fesoterodine—Nervous system disorder—Varenicline—nicotine dependence	0.00939	0.0145	CcSEcCtD
Fesoterodine—Tachycardia—Varenicline—nicotine dependence	0.00935	0.0145	CcSEcCtD
Fesoterodine—Skin disorder—Varenicline—nicotine dependence	0.0093	0.0144	CcSEcCtD
Fesoterodine—CHRM4—Monoamine GPCRs—DRD2—nicotine dependence	0.00892	0.0252	CbGpPWpGaD
Fesoterodine—Insomnia—Varenicline—nicotine dependence	0.00866	0.0134	CcSEcCtD
Fesoterodine—CHRM5—Monoamine GPCRs—DRD2—nicotine dependence	0.00854	0.0242	CbGpPWpGaD
Fesoterodine—Somnolence—Varenicline—nicotine dependence	0.00851	0.0132	CcSEcCtD
Fesoterodine—Dyspepsia—Varenicline—nicotine dependence	0.00843	0.013	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00827	0.0128	CcSEcCtD
Fesoterodine—Fatigue—Varenicline—nicotine dependence	0.00826	0.0128	CcSEcCtD
Fesoterodine—Constipation—Varenicline—nicotine dependence	0.00819	0.0127	CcSEcCtD
Fesoterodine—Feeling abnormal—Varenicline—nicotine dependence	0.00789	0.0122	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Varenicline—nicotine dependence	0.00783	0.0121	CcSEcCtD
Fesoterodine—Urticaria—Varenicline—nicotine dependence	0.00761	0.0118	CcSEcCtD
Fesoterodine—Abdominal pain—Varenicline—nicotine dependence	0.00757	0.0117	CcSEcCtD
Fesoterodine—CHRM4—Amine ligand-binding receptors—DRD2—nicotine dependence	0.0075	0.0212	CbGpPWpGaD
Fesoterodine—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.0074	0.0209	CbGpPWpGaD
Fesoterodine—CHRM5—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00718	0.0203	CbGpPWpGaD
Fesoterodine—Hypersensitivity—Varenicline—nicotine dependence	0.00706	0.0109	CcSEcCtD
Fesoterodine—CHRM4—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00687	0.0195	CbGpPWpGaD
Fesoterodine—Asthenia—Varenicline—nicotine dependence	0.00687	0.0106	CcSEcCtD
Fesoterodine—Pruritus—Varenicline—nicotine dependence	0.00678	0.0105	CcSEcCtD
Fesoterodine—CHRM5—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00658	0.0186	CbGpPWpGaD
Fesoterodine—Diarrhoea—Varenicline—nicotine dependence	0.00655	0.0101	CcSEcCtD
Fesoterodine—Dizziness—Varenicline—nicotine dependence	0.00633	0.00979	CcSEcCtD
Fesoterodine—CHRM4—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00608	0.0172	CbGpPWpGaD
Fesoterodine—Rash—Varenicline—nicotine dependence	0.00604	0.00934	CcSEcCtD
Fesoterodine—Dermatitis—Varenicline—nicotine dependence	0.00603	0.00933	CcSEcCtD
Fesoterodine—CHRM1—Monoamine GPCRs—DRD2—nicotine dependence	0.00601	0.017	CbGpPWpGaD
Fesoterodine—Headache—Varenicline—nicotine dependence	0.006	0.00928	CcSEcCtD
Fesoterodine—CHRM3—Monoamine GPCRs—DRD2—nicotine dependence	0.00599	0.017	CbGpPWpGaD
Fesoterodine—CHRM2—Monoamine GPCRs—DRD2—nicotine dependence	0.00594	0.0168	CbGpPWpGaD
Fesoterodine—Nausea—Varenicline—nicotine dependence	0.00569	0.0088	CcSEcCtD
Fesoterodine—CHRM1—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00505	0.0143	CbGpPWpGaD
Fesoterodine—CHRM3—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00504	0.0143	CbGpPWpGaD
Fesoterodine—CHRM2—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00499	0.0141	CbGpPWpGaD
Fesoterodine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0047	0.0133	CbGpPWpGaD
Fesoterodine—CHRM1—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00464	0.0131	CbGpPWpGaD
Fesoterodine—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00464	0.0131	CbGpPWpGaD
Fesoterodine—CHRM3—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00462	0.0131	CbGpPWpGaD
Fesoterodine—CHRM2—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00458	0.0129	CbGpPWpGaD
Fesoterodine—CHRM4—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00428	0.0121	CbGpPWpGaD
Fesoterodine—CHRM4—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.0041	0.0116	CbGpPWpGaD
Fesoterodine—CHRM5—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.0041	0.0116	CbGpPWpGaD
Fesoterodine—CHRM2—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00405	0.0115	CbGpPWpGaD
Fesoterodine—CHRM5—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00393	0.0111	CbGpPWpGaD
Fesoterodine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00381	0.0108	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR ligand binding—TAS2R16—nicotine dependence	0.00368	0.0104	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR ligand binding—TAS2R16—nicotine dependence	0.00353	0.00998	CbGpPWpGaD
Fesoterodine—CHRM2—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00347	0.00983	CbGpPWpGaD
Fesoterodine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00307	0.00869	CbGpPWpGaD
Fesoterodine—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00303	0.00858	CbGpPWpGaD
Fesoterodine—CHRM1—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00288	0.00816	CbGpPWpGaD
Fesoterodine—CHRM3—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00288	0.00814	CbGpPWpGaD
Fesoterodine—CHRM2—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00285	0.00806	CbGpPWpGaD
Fesoterodine—CHRM1—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00277	0.00783	CbGpPWpGaD
Fesoterodine—CHRM3—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00276	0.0078	CbGpPWpGaD
Fesoterodine—CHRM2—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00273	0.00773	CbGpPWpGaD
Fesoterodine—CHRM4—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00257	0.00726	CbGpPWpGaD
Fesoterodine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00249	0.00704	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR ligand binding—TAS2R16—nicotine dependence	0.00248	0.00703	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR ligand binding—TAS2R16—nicotine dependence	0.00248	0.00701	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR ligand binding—TAS2R16—nicotine dependence	0.00245	0.00694	CbGpPWpGaD
Fesoterodine—CHRM4—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00238	0.00674	CbGpPWpGaD
Fesoterodine—CHRM2—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00232	0.00656	CbGpPWpGaD
Fesoterodine—CHRM5—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00228	0.00645	CbGpPWpGaD
Fesoterodine—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00215	0.00607	CbGpPWpGaD
Fesoterodine—CHRM2—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.0021	0.00595	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00208	0.00589	CbGpPWpGaD
Fesoterodine—CHRM4—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00204	0.00577	CbGpPWpGaD
Fesoterodine—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.00202	0.00572	CbGpPWpGaD
Fesoterodine—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00199	0.00564	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00199	0.00564	CbGpPWpGaD
Fesoterodine—CHRM5—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00195	0.00553	CbGpPWpGaD
Fesoterodine—CHRM1—Circadian rythm related genes—CHRNB2—nicotine dependence	0.00192	0.00542	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—TAS2R16—nicotine dependence	0.00189	0.00535	CbGpPWpGaD
Fesoterodine—CHRM4—G alpha (i) signalling events—DRD2—nicotine dependence	0.00185	0.00525	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—TAS2R16—nicotine dependence	0.00181	0.00512	CbGpPWpGaD
Fesoterodine—CHRM4—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00172	0.00487	CbGpPWpGaD
Fesoterodine—CHRM2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00171	0.00483	CbGpPWpGaD
Fesoterodine—CHRM5—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00165	0.00466	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—FGD1—nicotine dependence	0.00163	0.00462	CbGpPWpGaD
Fesoterodine—CHRM1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00161	0.00454	CbGpPWpGaD
Fesoterodine—CHRM3—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.0016	0.00453	CbGpPWpGaD
Fesoterodine—CHRM2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00158	0.00448	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—FGD1—nicotine dependence	0.00156	0.00443	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR ligand binding—OPRM1—nicotine dependence	0.00155	0.00439	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR ligand binding—OPRM1—nicotine dependence	0.00149	0.00421	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—FGD1—nicotine dependence	0.00148	0.0042	CbGpPWpGaD
Fesoterodine—CHRM4—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00147	0.00417	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—FGD1—nicotine dependence	0.00142	0.00402	CbGpPWpGaD
Fesoterodine—CHRM1—Circadian rythm related genes—DRD2—nicotine dependence	0.00142	0.00401	CbGpPWpGaD
Fesoterodine—CHRM5—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00141	0.004	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.0014	0.00397	CbGpPWpGaD
Fesoterodine—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.0014	0.00397	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—TAS2R16—nicotine dependence	0.0014	0.00396	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00139	0.00392	CbGpPWpGaD
Fesoterodine—CHRM1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00138	0.00389	CbGpPWpGaD
Fesoterodine—CHRM3—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00137	0.00388	CbGpPWpGaD
Fesoterodine—CHRM2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00136	0.00384	CbGpPWpGaD
Fesoterodine—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.00132	0.00374	CbGpPWpGaD
Fesoterodine—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.0013	0.00369	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—TAS2R16—nicotine dependence	0.00127	0.00361	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—TAS2R16—nicotine dependence	0.00127	0.0036	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—TAS2R16—nicotine dependence	0.00126	0.00356	CbGpPWpGaD
Fesoterodine—CHRM2—G alpha (i) signalling events—DRD2—nicotine dependence	0.00123	0.00349	CbGpPWpGaD
Fesoterodine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00116	0.00328	CbGpPWpGaD
Fesoterodine—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00116	0.00327	CbGpPWpGaD
Fesoterodine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00115	0.00324	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR ligand binding—DRD2—nicotine dependence	0.00112	0.00318	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—TAS2R16—nicotine dependence	0.00112	0.00316	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—FGD1—nicotine dependence	0.0011	0.00312	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—FGD1—nicotine dependence	0.0011	0.00311	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—FGD1—nicotine dependence	0.00109	0.00308	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR ligand binding—DRD2—nicotine dependence	0.00108	0.00304	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—TAS2R16—nicotine dependence	0.00107	0.00303	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR ligand binding—OPRM1—nicotine dependence	0.00105	0.00296	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR ligand binding—OPRM1—nicotine dependence	0.00104	0.00295	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR ligand binding—OPRM1—nicotine dependence	0.00103	0.00293	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—FGD1—nicotine dependence	0.001	0.00283	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—FGD1—nicotine dependence	0.000997	0.00282	CbGpPWpGaD
Fesoterodine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000994	0.00281	CbGpPWpGaD
Fesoterodine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000991	0.0028	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—FGD1—nicotine dependence	0.000987	0.00279	CbGpPWpGaD
Fesoterodine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000981	0.00278	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—OPRM1—nicotine dependence	0.000878	0.00248	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—FGD1—nicotine dependence	0.000876	0.00248	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—OPRM1—nicotine dependence	0.00084	0.00238	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—FGD1—nicotine dependence	0.000839	0.00237	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—OPRM1—nicotine dependence	0.000797	0.00226	CbGpPWpGaD
Fesoterodine—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000784	0.00222	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—AKR1B10—nicotine dependence	0.000774	0.00219	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—OPRM1—nicotine dependence	0.000763	0.00216	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR ligand binding—DRD2—nicotine dependence	0.000757	0.00214	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR ligand binding—DRD2—nicotine dependence	0.000755	0.00214	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—TAS2R16—nicotine dependence	0.000753	0.00213	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—TAS2R16—nicotine dependence	0.000751	0.00212	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR ligand binding—DRD2—nicotine dependence	0.000747	0.00211	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—TAS2R16—nicotine dependence	0.000743	0.0021	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—AKR1B10—nicotine dependence	0.000741	0.0021	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—DRD2—nicotine dependence	0.000635	0.0018	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—DRD2—nicotine dependence	0.000608	0.00172	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000592	0.00167	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—FGD1—nicotine dependence	0.000591	0.00167	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—OPRM1—nicotine dependence	0.00059	0.00167	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—FGD1—nicotine dependence	0.000589	0.00167	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—OPRM1—nicotine dependence	0.000584	0.00165	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—FGD1—nicotine dependence	0.000583	0.00165	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—CYP2A7—nicotine dependence	0.000579	0.00164	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—DRD2—nicotine dependence	0.000576	0.00163	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—DRD2—nicotine dependence	0.000552	0.00156	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—WASF2—nicotine dependence	0.000545	0.00154	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—OPRM1—nicotine dependence	0.000537	0.00152	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—OPRM1—nicotine dependence	0.000536	0.00152	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—OPRM1—nicotine dependence	0.000531	0.0015	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—WASF1—nicotine dependence	0.000523	0.00148	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—WASF2—nicotine dependence	0.000522	0.00148	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—AKR1B10—nicotine dependence	0.000522	0.00148	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—AKR1B10—nicotine dependence	0.00052	0.00147	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—AKR1B10—nicotine dependence	0.000515	0.00146	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—WASF1—nicotine dependence	0.000501	0.00142	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—OPRM1—nicotine dependence	0.000471	0.00133	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—OPRM1—nicotine dependence	0.000451	0.00128	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—DRD2—nicotine dependence	0.000428	0.00121	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—DRD2—nicotine dependence	0.000426	0.00121	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—DRD2—nicotine dependence	0.000422	0.0012	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—DRD2—nicotine dependence	0.000389	0.0011	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—DRD2—nicotine dependence	0.000387	0.0011	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—DRD2—nicotine dependence	0.000384	0.00109	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—WASF2—nicotine dependence	0.000368	0.00104	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CYP2A7—nicotine dependence	0.000367	0.00104	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—WASF2—nicotine dependence	0.000367	0.00104	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—WASF2—nicotine dependence	0.000363	0.00103	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—WASF1—nicotine dependence	0.000353	0.000998	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—WASF1—nicotine dependence	0.000351	0.000995	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—WASF1—nicotine dependence	0.000348	0.000985	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.000346	0.000979	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—DRD2—nicotine dependence	0.00034	0.000963	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—DRD2—nicotine dependence	0.000326	0.000922	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—OPRM1—nicotine dependence	0.000317	0.000898	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—OPRM1—nicotine dependence	0.000316	0.000895	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—OPRM1—nicotine dependence	0.000313	0.000887	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—DRD2—nicotine dependence	0.00023	0.000649	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—DRD2—nicotine dependence	0.000229	0.000647	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—DRD2—nicotine dependence	0.000227	0.000641	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CYP2A7—nicotine dependence	0.000226	0.00064	CbGpPWpGaD
